Trials / Conditions / Locally Advanced Sarcoma
Locally Advanced Sarcoma
6 registered clinical trials studyying Locally Advanced Sarcoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Cemiplimab for Secondary Angiosarcomas NCT04873375 | Radboud University Medical Center | Phase 2 |
| Active Not Recruiting | Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in NCT04595747 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Sol NCT04771520 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy NCT02732015 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants Wit NCT02609984 | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Completed | Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas NCT01106872 | Mohammed M Milhem | Phase 1 |